Pharmacy Board of Australia sets fee for 2020–21

18 Sep 2020

The Pharmacy Board of Australia (the Board) has announced the national registration fee for pharmacy for 2020–21.

The Board has increased the registration fee by indexation to $420.

The fee for practitioners whose principal place of practice is New South Wales is $492¹. For more information about the variation in the fee for practitioners whose principal place of practice is NSW, please see the Pharmacy Council of New South Wales website.

A full fee schedule, including the fee arrangements for practitioners whose principal place of practice is NSW, is published on the Board’s website.

The Board’s decision to increase the fee by indexation for the 2020–21 period ensures the Board has sufficient income to allow it to carry out its duties and protect the public.

The Board is committed to keeping the fee as low as possible, while meeting its regulatory obligations to protect the public.

The Board recognises that this is a challenging time for health practitioners and sincerely thanks practitioners for their continuing commitment and professionalism. Ahpra and the Board have adapted regulatory approaches to support practitioners during these difficult circumstances including introducing a COVID-19 financial hardship payment plan. To read more about the payment plan, including how to apply, see the Ahpra COVID-19 updates page.

Practitioner registration fees fund the National Registration and Accreditation and support the Board’s continuing efforts to support and develop a safe and mobile Australian workforce for registered health practitioners and the public in the most efficient way possible.

Registration fees also allow the Board to facilitate the provision of high-quality education and training for practitioners.

For more information

• Read the media release from Ahpra and National Boards on the Ahpra website.
• Visit the Pharmacy Board of Australia's website.
• For online enquiries visit www.ahpra.gov.au/enquiry.
• For registration enquiries: 1300 419 495 (within Australia) +61 3 8708 9009 (overseas callers).

¹NSW is a co-regulatory jurisdiction.